Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer
Kazuki Kano(Kanagawa Prefectural Hospital Organization), Takashi Oshima(Kanagawa Prefectural Hospital Organization), Naoto Yamamoto(Kanagawa Prefectural Hospital Organization), Soichiro Morinaga(Kanagawa Prefectural Hospital Organization), Takaki Yoshikawa(Tokyo National Hospital), Hirohito Fujikawa(Kanagawa Prefectural Hospital Organization), Takanobu Yamada(Kanagawa Prefectural Hospital Organization), Manabu Shiozawa(Kanagawa Prefectural Hospital Organization), Yasushi Rino(Yokohama City University Hospital), Haruhiko Cho(Tokyo Metropolitan Komagome Hospital), Norio Yukawa(Yokohama City University), Kouji Yamamoto(Yokohama City University), Takashi Ogata(Kanagawa Prefectural Hospital Organization), Munetaka Masuda(Uji Hospital), Yukio Maezawa(Yokohama City University), Hayato Watanabe(Hiratsuka Kyosai Hospital), Hiroshi Tamagawa(Yokohama Minami Kyosai Hospital), KEISUKE KOMORI(Kanagawa Prefectural Hospital Organization), Toru Aoyama(Yokohama City University), Yota Shimoda(Kanagawa Prefectural Hospital Organization), Kentaro Hara(Yokohama City University)
Cited by 49
Related Papers
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
|The Lancet Oncology|2023|336
Confidence interval for micro-averaged F1 and macro-averaged F1 scores
|Applied Intelligence|2021|273
Drug physical state and drug–polymer interaction on drug release from chitosan matrix films
|Journal of Controlled Release|2001|237